Paper17523705
Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany.
Koch H and 2 others. Clin Drug Investig, 2004. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany. Papers, record 17523705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17523705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17535055 | Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study. | Clin Drug Investig | 2003 | https://conductscience.org/library/papers/17535055 | PubMed |
| 2 | 10577109 | Fluoroquinolone resistance in Streptococcus pneumoniae. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10577109 | PubMed |
| 3 | 11393351 | Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective. | J Int Med Res | 2001 | https://conductscience.org/library/papers/11393351 | PubMed |
| 4 | 11850164 | Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative. | Int J Antimicrob Agents | 2002 | https://conductscience.org/library/papers/11850164 | PubMed |
| 5 | 11052424 | Antibiotic therapy in acute exacerbations of chronic bronchitis. | Semin Respir Infect | 2000 | https://conductscience.org/library/papers/11052424 | PubMed |
| 6 | 10843981 | Infectious etiology of acute exacerbations of chronic bronchitis. | Chest | 2000 | https://conductscience.org/library/papers/10843981 | PubMed |
| 7 | 15006954 | Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. | Chest | 2004 | https://conductscience.org/library/papers/15006954 | PubMed |
| 8 | 11863209 | Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. | Respir Med | 2002 | https://conductscience.org/library/papers/11863209 | PubMed |
| 9 | 9552014 | The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. | Chest | 1998 | https://conductscience.org/library/papers/9552014 | PubMed |
| 10 | 11389122 | Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae. | J Antimicrob Chemother | 2001 | https://conductscience.org/library/papers/11389122 | PubMed |
| 11 | 9603117 | Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. | Am J Respir Crit Care Med | 1998 | https://conductscience.org/library/papers/9603117 | PubMed |
| 12 | 10588312 | Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. | J Antimicrob Chemother | 1999 | https://conductscience.org/library/papers/10588312 | PubMed |
| 13 | 11393350 | Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients. | J Int Med Res | 2001 | https://conductscience.org/library/papers/11393350 | PubMed |
| 14 | 12740290 | Interpreting COPD prevalence estimates: what is the true burden of disease? | Chest | 2003 | https://conductscience.org/library/papers/12740290 | PubMed |
| 15 | 11796368 | Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11796368 | PubMed |
| 16 | 12181400 | New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. | N Engl J Med | 2002 | https://conductscience.org/library/papers/12181400 | PubMed |
| 17 | 10596683 | Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. | Eur Respir J | 1999 | https://conductscience.org/library/papers/10596683 | PubMed |
| 18 | 10795599 | Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. | Eur J Clin Microbiol Infect Dis | 2000 | https://conductscience.org/library/papers/10795599 | PubMed |
| 19 | 10639387 | Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10639387 | PubMed |
| 20 | 11320449 | Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. | Clin Infect Dis | 2001 | https://conductscience.org/library/papers/11320449 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22715866 | Moxifloxacin safety: an analysis of 14 years of clinical data. | Drugs R D | 2012 | https://conductscience.org/library/papers/22715866 | PubMed |
| 19419232 | Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. | Drug Saf | 2009 | https://conductscience.org/library/papers/19419232 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17523705
GET https://conductscience.org/api/papers/v1/17523705/references?page=2